Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

217 ARTÍCULOS , VIENDO DEL 151 AL 165

The FDA-approved anti-amyloid-β monoclonal antibodies for the treatment of Alzheimer's disease: a systematic review and meta-analysis of randomized controlled trials

Wu W, Ji Y, Wang Z, Wu X, Li J, Gu F, Chen Z, Wang Z.

Eur J Med Res. 2023 Nov 28;28(1):544. doi: 10.1186/s40001-023-01512-w.

Validating blood tests as a possible routine diagnostic assay of Alzheimer's disease

Kodosaki E, Zetterberg H, Heslegrave A.

Expert Rev Mol Diagn. 2023 Jul-Dec;23(12):1153-1165. doi: 10.1080/14737159.2023.2289553. Epub 2023 Dec 15.

Cerebrospinal and Blood Biomarkers in Alzheimer's Disease: Did Mild Cognitive Impairment Definition Affect Their Clinical Usefulness?

Bivona G, Iemmolo M, Ghersi G.

Int J Mol Sci. 2023 Nov 29;24(23):16908. doi: 10.3390/ijms242316908.

Longitudinal cerebrospinal fluid measurements show glial hypo- and hyperactivation in predementia Alzheimer's disease

Nordengen K, Kirsebom BE, Richter G, Pålhaugen L, Gísladóttir B, Siafarikas N, Nakling A, Rongve A, Bråthen G, Grøntvedt GR, Gonzalez F, Waterloo K, Sharma K, Karikari T, Vromen EM, Tijms BM, Visser PJ, Selnes P, Kramberger MG, Winblad B, Blennow K, Fladby T.

J Neuroinflammation. 2023 Dec 13;20(1):298. doi: 10.1186/s12974-023-02973-w.

Blood Neurofilament Levels Predict Cognitive Decline across the Alzheimer's Disease Continuum

Lehmann S, Schraen-Maschke S, Vidal JS, Blanc F, Paquet C, Allinquant B, Bombois S, Gabelle A, Delaby C, Hanon O; BALTAZAR Study Group.

Int J Mol Sci. 2023 Dec 11;24(24):17361. doi: 10.3390/ijms242417361.

Biological Diagnosis of Alzheimer's Disease Based on Amyloid Status: An Illustration of Confirmation Bias in Medical Research?

Souchet B, Michaïl A, Billoir B, Braudeau J.

Int J Mol Sci. 2023 Dec 16;24(24):17544. doi: 10.3390/ijms242417544.

The Role of CSF Transthyretin in Human Alzheimer's Disease: Offense, Defense, or not so Innocent Bystander

Buxbaum JN.

J Integr Neurosci. 2023 Nov 6;22(6):158. doi: 10.31083/j.jin2206158.

Reactive astrogliosis: A friend or foe in the pathogenesis of Alzheimer's disease

Kumar A, Fontana IC, Nordberg A.

J Neurochem. 2023 Feb;164(3):309-324. doi: 10.1111/jnc.15565. Epub 2022 Jan 7.

Results and insights from a phase I clinical trial of Lomecel-B for Alzheimer's disease

Brody M, Agronin M, Herskowitz BJ, Bookheimer SY, Small GW, Hitchinson B, Ramdas K, Wishard T, McInerney KF, Vellas B, Sierra F, Jiang Z, Mcclain-Moss L, Perez C, Fuquay A, Rodriguez S, Hare JM, Oliva AA Jr, Baumel B.

Alzheimers Dement. 2023 Jan;19(1):261-273. doi: 10.1002/alz.12651. Epub 2022 Mar 31.

Subjective cognitive decline and stage 2 of Alzheimer disease in patients from memory centers

Jessen F, Wolfsgruber S, Kleineindam L, Spottke A, Altenstein S, Bartels C, Berger M, Brosseron F, Daamen M, Dichgans M, Dobisch L, Ewers M, Fenski F, Fliessbach K, Freiesleben SD, Glanz W, Görß D, Gürsel S, Janowitz D, Kilimann I, Kobeleva X, Lohse A, Maier F, Metzger C, Munk M, Preis L, Sanzenbacher C, Spruth E, Rauchmann B, Vukovich R, Yakupov R, Weyrauch AS, Ziegler G, Schmid M, Laske C, Perneczky R, Schneider A, Wiltfang J, Teipel S, Bürger K, Priller J, Peters O, Ramirez A, Boecker H, Heneka MT, Wagner M, Düzel E.

Alzheimers Dement. 2023 Feb;19(2):487-497. doi: 10.1002/alz.12674. Epub 2022 Apr 22.

Recent Advances in Frontotemporal Dementia

Tartaglia MC, Mackenzie IRA.

Can J Neurol Sci. 2023 Jul;50(4):485-494. doi: 10.1017/cjn.2022.69. Epub 2022 May 30.

Effect of nutritional supports on malnutrition, cognition, function and biomarkers of Alzheimer's disease: a systematic review

Kocatürk RR, Temizyürek A, Özcan ÖÖ, Ergüzel TT, Karahan M, Konuk M, Tarhan N.

Int J Neurosci. 2023 Dec;133(12):1355-1373. doi: 10.1080/00207454.2022.2079506. Epub 2022 Jul 3.

Comparative analytical performance of multiple plasma Aβ42 and Aβ40 assays and their ability to predict positron emission tomography amyloid positivity

Zicha S, Bateman RJ, Shaw LM, Zetterberg H, Bannon AW, Horton WA, Baratta M, Kolb HC, Dobler I, Mordashova Y, Saad ZS, Raunig DL, Spanakis EM, Li Y, Schindler SE, Ferber K, Rubel CE, Martone RL, Weber CJ, Edelmayer RM, Meyers EA, Bollinger JG, Rosenbaugh EG, Potter WZ; Alzheimer's Disease Neuroimaging Initiative (ADNI); Foundation for the National Institutes of Health (FNIH) Biomarkers Consortium Plasma Aβ as a Predictor of Amyloid Positivity in Alzheimer's Disease Project Team.

Alzheimers Dement. 2023 Mar;19(3):956-966. doi: 10.1002/alz.12697. Epub 2022 Jul 12.

CD33 isoforms in microglia and Alzheimer's disease: Friend and foe

Eskandari-Sedighi G, Jung J, Macauley MS.

Mol Aspects Med. 2023 Apr;90:101111. doi: 10.1016/j.mam.2022.101111. Epub 2022 Aug 5.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias